TBH, I don't even see why there's a spat
All it matters is whether they get their EU clearance. If you're confident on the decision who cares what the price does in between
I'm confident that because they haven't announced the need for additional clinical data and the fact that we have a sophisticated investor coming on (presumably after speaking to management and reviewing info) that the delay only relates to manufacturing and the sheer volume of data presented. Remember this is a radioactive product, two pages of overview won't cut it
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |